Other
Interest Paid, Net
Royalty Pharma Interest Paid, Net increased by 2497.3% to $173.53M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.0%, from $138.82M to $173.53M. Over 4 years (FY 2021 to FY 2025), Interest Paid, Net shows an upward trend with a 20.6% CAGR.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026
Metric ID:
ms_interest_paid_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $65.26M | $671.00K | $86.22M | $664.00K | $82.60M | $663.00K | $82.59M | $663.00K | $82.59M | $3.33M | $78.97M | $797.00K | $79.00M | $805.00K | $138.82M | $796.00K | $129.99M | $6.68M | $173.53M |
| QoQ Change | — | — | -99.0% | >999% | -99.2% | >999% | -99.2% | >999% | -99.2% | >999% | -96.0% | >999% | -99.0% | >999% | -99.0% | >999% | -99.4% | >999% | -94.9% | >999% |
| YoY Change | — | — | — | — | — | +26.6% | -1.2% | -4.2% | -0.2% | -0.0% | +401.8% | -4.4% | +20.2% | -4.3% | -75.8% | +75.8% | -0.1% | +64.6% | +729.9% | +25.0% |
Range$0.00 – $173.53M
Avg YoY Growth+83.6%
Median YoY Growth-0.0%
Interest Paid, Net at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's interest paid, net?
- Royalty Pharma (RPRX) reported interest paid, net of $173.53M in Q1 2026.
- How has Royalty Pharma's interest paid, net changed year-over-year?
- Royalty Pharma's interest paid, net increased by 25.0% year-over-year, from $138.82M to $173.53M.
- What is the long-term trend for Royalty Pharma's interest paid, net?
- Over 4 years (2021 to 2025), Royalty Pharma's interest paid, net has grown at a 20.6% compound annual growth rate (CAGR), from $130.43M to $276.29M.